Showing results (1361-1370 of 1,573) with videos related to

Sort By:
Pageof 158
AIDS (London, England)|July 24, 2019
Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive womenLaura E Richert-Spuhler, Laura Pattacini, Margot Plews, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 14, 2015
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patientsMike P Wattjes, Martijn T Wijburg, Anke Vennegoor, et al.
FEMS Microbiology Ecology|April 1, 2008
Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotypeMaria C Walsh, Gillian E Gardiner, Orla M Hart, et al.
Neurology|May 11, 2012
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MSS E Bushnell, Z Zhao, C C Stebbins, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
Journal of Reproductive Immunology|June 11, 2018
Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancySusanne Maria Ziegler, Cai Niklaas Feldmann, Sven Hendrik Hagen, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 18, 2015
Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testingAlice Limonciel, Konrad Moenks, Sven Stanzel, et al.
Plos One|August 10, 2017
Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cellsGlòria Martrus, Tobias Kautz, Sebastian Lunemann, et al.
Plos One|December 1, 2018
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidatesAnne-Laure Flamar, Henri Bonnabau, Sandra Zurawski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2016
Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine: A Substudy of the NEAT001/ANRS143 TrialAlan Winston, Wolfgang Stöhr, Andrea Antinori, et al.
Pageof 158